发明名称 CRYSTALLINE FORM OF PYRIMIDIO[6,1-A]ISOQUINOLIN-4-ONE COMPOUND
摘要 The current invention is directed towards a polymorph of N-{2-[(2E)-2-(mesitylimino)-9,10-dimethoxy-4-oxo-6,7-dihydro-2H-pyrimido[6,1-a]-isoquinolin-3(4H)-yl]ethyl}urea, in the form of a crystalline solid consisting of greater than 99% by weight of N-{2-[(2E)-2-(mesitylimino)-9,10-dimethoxy-4-oxo-6,7-dihydro-2H-pyrimido[6,1-a]-isoquinoIin-3(4H)-yl]ethyl}urea, at least 95% in the polymorphic form of a thermodynamically stable polymorph (I) of N-{2-[(2E)-2-(mesitylimino)-9,10-dimetlioxy-4-oxo-6,7-dihydro-2H-pyrimido[6,1-a]-isoquinolin-3(4H)-yl]ethyl}urea, wherein said polymorph is determined by single crystal X-ray structural analysis and X-ray powder diffraction pattern.
申请公布号 CA2807082(A1) 申请公布日期 2012.02.16
申请号 CA20112807082 申请日期 2011.08.09
申请人 VERONA PHARMA PLC 发明人 WALKER, MICHAEL, J., A.;PLOUVIER, BERTRAND, M., C.;NORTHEN, JULIAN, S.;FERNANDES, PHILIPPE
分类号 C07D471/04;A61K31/519;A61P11/00 主分类号 C07D471/04
代理机构 代理人
主权项
地址